Correlation Between Tanvex BioPharma and Genovate Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tanvex BioPharma and Genovate Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tanvex BioPharma and Genovate Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tanvex BioPharma and Genovate Biotechnology Co, you can compare the effects of market volatilities on Tanvex BioPharma and Genovate Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tanvex BioPharma with a short position of Genovate Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tanvex BioPharma and Genovate Biotechnology.

Diversification Opportunities for Tanvex BioPharma and Genovate Biotechnology

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between Tanvex and Genovate is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Tanvex BioPharma and Genovate Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genovate Biotechnology and Tanvex BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tanvex BioPharma are associated (or correlated) with Genovate Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genovate Biotechnology has no effect on the direction of Tanvex BioPharma i.e., Tanvex BioPharma and Genovate Biotechnology go up and down completely randomly.

Pair Corralation between Tanvex BioPharma and Genovate Biotechnology

Assuming the 90 days trading horizon Tanvex BioPharma is expected to generate 2.95 times more return on investment than Genovate Biotechnology. However, Tanvex BioPharma is 2.95 times more volatile than Genovate Biotechnology Co. It trades about 0.0 of its potential returns per unit of risk. Genovate Biotechnology Co is currently generating about -0.09 per unit of risk. If you would invest  7,200  in Tanvex BioPharma on September 28, 2024 and sell it today you would lose (1,000.00) from holding Tanvex BioPharma or give up 13.89% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Tanvex BioPharma  vs.  Genovate Biotechnology Co

 Performance 
       Timeline  
Tanvex BioPharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tanvex BioPharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Genovate Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genovate Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Tanvex BioPharma and Genovate Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tanvex BioPharma and Genovate Biotechnology

The main advantage of trading using opposite Tanvex BioPharma and Genovate Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tanvex BioPharma position performs unexpectedly, Genovate Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genovate Biotechnology will offset losses from the drop in Genovate Biotechnology's long position.
The idea behind Tanvex BioPharma and Genovate Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity